We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

49 hedge funds and large institutions have $12.8M invested in Anixa Biosciences in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

20,400% more call options, than puts

Call options by funds: $205K | Put options by funds: $1K

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

10% more capital invested

Capital invested by funds: $11.7M → $12.8M (+$1.17M)

9% more funds holding

Funds holding: 45 → 49 (+4)

0.87% more ownership

Funds ownership: 11.77% → 12.64% (+0.87%)

60% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 15

Holders
49
Holders Change
+4
Holders Change %
+8.89%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
15
Closed
3
Calls
$205K
Puts
$1K
Net Calls
+$204K
Net Calls Change
+$66K

Top Buyers

Rank Fund Capital Flow
1
MWM
Mission Wealth Management
California
+$1.75M
2
DWM
Dakota Wealth Management
Florida
+$52.5K
3
Squarepoint
Squarepoint
New York
+$47.3K
4
TRCT
Tower Research Capital (TRC)
New York
+$44.1K
5
LPL Financial
LPL Financial
California
+$18.4K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$315K
2
Renaissance Technologies
Renaissance Technologies
New York
-$173K
3
Stifel Financial
Stifel Financial
Missouri
-$160K
4
UBS Group
UBS Group
Switzerland
-$104K
5
SBH
Segall Bryant & Hamill
Illinois
-$55.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
26
Simplicity Solutions
Minnesota
$50.6K -$77 -22 -0.1%
NFG
27
Nations Financial Group
Iowa
$49K – – –
DWM
28
Dakota Wealth Management
Florida
$49K +$52.5K +15,000 New
IAIM
29
International Assets Investment Management
Florida
$47.1K – – –
Squarepoint
30
Squarepoint
New York
$44.2K +$47.3K +13,514 New
WIM
31
Westside Investment Management
California
$42.2K -$3.15K -900 -7%
Charles Schwab
32
Charles Schwab
California
$41.8K – – –
Renaissance Technologies
33
Renaissance Technologies
New York
$33K -$173K -49,300 -83%
ATC
34
Adirondack Trust Company
New York
$22.8K – – –
TWM
35
Tradition Wealth Management
Minnesota
$18K +$2.1K +600 +12%
PNC Financial Services Group
36
PNC Financial Services Group
Pennsylvania
$9.94K +$10.6K +3,039 New
Group One Trading
37
Group One Trading
Illinois
$5.22K -$15.3K -4,373 -73%
AA
38
Ancora Advisors
Ohio
$4.98K – – –
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$3K -$647 -185 -14%
Simplex Trading
40
Simplex Trading
Illinois
$3K +$3.55K +1,014 New
Wells Fargo
41
Wells Fargo
California
$2.37K +$10 +3 +0.4%
LFG
42
Larson Financial Group
Missouri
$1.72K – – –
PCC
43
Park Circle Company
Maryland
$1.64K +$1.75K +500 New
Osaic Holdings
44
Osaic Holdings
Arizona
$1.31K – – –
US Bancorp
45
US Bancorp
Minnesota
$1.31K – – –
BC
46
Barrett & Company
Rhode Island
$261 – – –
S
47
SignatureFD
Georgia
$186 – – –
TAM
48
Tucker Asset Management
Colorado
$33 – – –
Qube Research & Technologies (QRT)
49
Qube Research & Technologies (QRT)
United Kingdom
$13 +$14 +4 New
Stifel Financial
50
Stifel Financial
Missouri
– -$160K -50,000 Closed
1
2
3

ANIX Hedge Fund Activity: Q3 2023 in Review

49 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q3 2023, worth a combined $12.8M — up 10% from $11.7M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ANIX positions and 3 closed out — a net gain of 4 holders — while 6 added to existing stakes and 15 trimmed.

The largest buyer was Mission Wealth Management, opening a new position worth an estimated $1.75M. The largest seller was BlackRock, cutting an estimated $315K.

  • 49 institutional investors held Anixa Biosciences (ANIX) as of Q3 2023, up from 45 in Q2 2023.
  • Funds reported $12.8M of Anixa Biosciences stock for Q3 2023, up 10% quarter-over-quarter.
  • 7 funds opened new Anixa Biosciences positions in Q3 2023 and 3 closed out, a net change of +4 holders.
  • The largest Anixa Biosciences buyer in Q3 2023 was Mission Wealth Management, an estimated $1.75M added.
  • The largest Anixa Biosciences seller in Q3 2023 was BlackRock, an estimated $315K sold.

Based on aggregated 13F filings for Q3 2023.